---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013285"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-06-02T23:59:59+00:00"
generated_at: "2026-05-20T02:43:29.130119+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $60,000 promissory note to accredited investor

## Summary
- Principal amount $60,000; purchase price $50,000 (implicit $10,000 discount).
- Maturity July 15, 2025; interest at 10% per annum.
- Repayment at 100% of principal if on/before July 7, 2025; 120% if after through Aug 7, 2025.
- Proceeds for general working capital; note issued under Section 4(a)(2) private placement.

## SEC filing metadata
- accession: 0001641172-25-013285
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-06-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/0001641172-25-013285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013285
- JSON: https://secwatch.observer/filing/0001641172-25-013285.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013285.txt

## Key facts
- Debt Financings
  Propanc Biopharma, Inc. incurred loan of $60,000 with an accredited investor at ten percent (10%) per annum maturing July 15, 2025.
  - Instrument: loan
  - Principal: $60,000
  - Counterparty: an accredited investor
  - Rate: ten percent (10%) per annum
  - Maturity: July 15, 2025
  - Event: incurrence
  source text: Effective June 2, 2025, Propanc Biopharma, Inc. (the “Company”) issued a Promissory Note to an accredited investor (the “Investor”) in the aggregate principal amount of $60,000 (the “Note”), for a purchase price of $50,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517681/000164117225013285/0001641172-25-013285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.